Cargando…
Extensive deep vein thrombosis treatment using fondaparinux and edoxaban: a case report
BACKGROUND: Factor Xa inhibitor is a key drug in the coagulation cascade. Parenteral anticoagulation using low molecular weight heparin or fondaparinux is the recommended form of treatment for most patients presenting with venous thrombosis. Following the acute phase, edoxaban is recommended. We pre...
Autores principales: | Shimizu, Kazuhiro, Sasaki, Takeshi, Tomaru, Takanobu, Noike, Hirofumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962499/ https://www.ncbi.nlm.nih.gov/pubmed/27468257 http://dx.doi.org/10.1186/s12959-016-0089-x |
Ejemplares similares
-
The clinical course of symptomatic deep vein thrombosis after 3 months of anticoagulant therapy using fondaparinux/edoxaban or fondaparinux/vitamin K antagonist
por: Shimizu, Kazuhiro, et al.
Publicado: (2018) -
Thrombosis in an Internal Jugular Vein and an Upper Limb Deep Vein Treated with Edoxaban
por: Toratani, Mizuho, et al.
Publicado: (2017) -
Superior mesenteric vein thrombosis treated with edoxaban
por: Hashizume, Yutaka, et al.
Publicado: (2017) -
Edoxaban Was Effective for the Treatment of Deep Vein Thrombosis and Pulmonary Thromboembolism in a Cancer Patient with Antithrombin III Deficiency
por: Kawano, Hiroaki, et al.
Publicado: (2016) -
Fondaparinux is effective for acute portal vein thrombosis in decompensated cirrhotic patients
por: Zhang, Zhi-Hao, et al.
Publicado: (2017)